Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|June 30, 2000
Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumorsM J Engelen, H W de Bruijn, H Hollema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinomaJ M Duk, K H Groenier, H W de Bruijn, et al.
Journal of Clinical Pathology|May 1, 1995
Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinomaM F Baay, J M Duk, M P Burger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervixE Pras, P H Willemse, H Boonstra, et al.
Cancer|February 15, 1995
Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet countsA G van der Zee, E M de Cuyper, P C Limburg, et al.
Gynecologic Oncology|August 1, 1995
Cell biological markers of drug resistance in ovarian carcinomaA G van der Zee, H H Hollema, H W de Bruijn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experienceM E Gels, H J Hoekstra, D T Sleijfer, et al.
British Journal of Cancer|April 17, 1999
Ovarian cysts in women receiving tamoxifen for breast cancerM J Mourits, E G de Vries, P H Willemse, et al.
British Journal of Cancer|November 1, 1992
Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markersB Biesma, P H Willemse, N H Mulder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancerM D Esajas, J M Duk, H W de Bruijn, et al.
Pageof 7